395 related articles for article (PubMed ID: 15819586)
1. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents.
Zimarino M; Renda G; De Caterina R
Drugs; 2005; 65(6):725-32. PubMed ID: 15819586
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
3. Influence of low-dose aspirin (81 mg) on the incidence of definite stent thrombosis in patients receiving bare-metal and drug-eluting stents.
Lotfi A; Cui J; Wartak S; Columbo J; Mulvey S; Davis M; Schweiger M; Giugliano GR
Clin Cardiol; 2011 Sep; 34(9):567-71. PubMed ID: 21792981
[TBL] [Abstract][Full Text] [Related]
4. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study.
Byrne RA; Schulz S; Mehilli J; Iijima R; Massberg S; Neumann FJ; ten Berg JM; Schömig A; Kastrati A;
Am Heart J; 2009 Apr; 157(4):620-4.e2. PubMed ID: 19332187
[TBL] [Abstract][Full Text] [Related]
6. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.
Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Cheong SS; Kim JJ; Park SW; Park SJ
JACC Cardiovasc Interv; 2008 Oct; 1(5):494-503. PubMed ID: 19463351
[TBL] [Abstract][Full Text] [Related]
7. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
[TBL] [Abstract][Full Text] [Related]
8. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial.
Lee H; Koo BK; Park KW; Shin ES; Lim SW; Rha SW; Bae JW; Jeon DW; Oh SK; Hur SH; Kim BS; Lee JH; Park TH; Lee NH; Kim HS;
Am Heart J; 2017 Mar; 185():17-25. PubMed ID: 28267471
[TBL] [Abstract][Full Text] [Related]
10. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
Faxon DP; Lawler E; Young M; Gaziano M; Kinlay S
Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
12. [Dual antithrombotic therapy after implantation of coronary stents].
Schneider H; Weber F; Holzhausen C; Körber T; Ince H; Rehders T; Nienaber CA
Dtsch Med Wochenschr; 2006 May; 131(19):1105-10. PubMed ID: 16685632
[TBL] [Abstract][Full Text] [Related]
13. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
Eisenstein EL; Anstrom KJ; Kong DF; Shaw LK; Tuttle RH; Mark DB; Kramer JM; Harrington RA; Matchar DB; Kandzari DE; Peterson ED; Schulman KA; Califf RM
JAMA; 2007 Jan; 297(2):159-68. PubMed ID: 17148711
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study.
Biondi-Zoccai GG; Agostoni P; Sangiorgi GM; Iakovou I; Antoniucci D; Grube E; Tamburino C; Di Mario C; Reimers B; Michev I; Goktekin O; Airoldi F; Chieffo A; Cosgrave J; Tassanawiwat W; Colombo A;
Int J Cardiol; 2006 Apr; 108(3):406-7. PubMed ID: 16520130
[TBL] [Abstract][Full Text] [Related]
16. Post percutaneous coronary intervention antiplatelet therapy: current perceptions, prospects and perplexity.
Pant S; Neupane P; Ramesh KC; Barakoti M
Cardiol J; 2011; 18(6):712-7. PubMed ID: 22113766
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
Mauri L; Kereiakes DJ; Normand SL; Wiviott SD; Cohen DJ; Holmes DR; Bangalore S; Cutlip DE; Pencina M; Massaro JM
Am Heart J; 2010 Dec; 160(6):1035-41, 1041.e1. PubMed ID: 21146655
[TBL] [Abstract][Full Text] [Related]
19. [Stents in interventional cardiology].
Grinius V; Navickas R; Unikas R
Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.
Al-Dehneh A; Virk H; Alkhouri Y; Hamdan A; Bikkina M
Tex Heart Inst J; 2010; 37(3):343-6. PubMed ID: 20548819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]